ACTINIUM PHARMACEUTICALS, INC. Entertainment, License Agreement for Program Material, Capitalized Cost
ACTINIUM PHARMACEUTICALS, INC. (ATNM) had Entertainment, License Agreement for Program Material, Capitalized Cost of $1.00 million as of 2012-06-15, per its 10-Q filed 2023-11-02.
Discontinued › Notes
us-gaap:EntertainmentLicenseAgreementForProgramMaterialCapitalizedCost · last filed 2023-11-02
- 2012-06-15: Entertainment, License Agreement for Program Material, Capitalized Cost $1.00M.
| Period end | Entertainment, License Agreement for Program Material, Capitalized Cost |
|---|---|
| 2012-06-15 | $1.00M 10-Q · filed 2023-11-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |